Back

Seeded aggregation of ANXA11 induces prion-like propagation, TDP-43 co-pathology and nucleocytoplasmic transport defects

Luo, H.; Zheng, H.; Lu, Y.; Lu, C.; Zhang, K.; Duan, S.; Zhang, H.; Zhang, Y.; Song, Y.; Wang, T.; Liu, H.; Xia, Z.; Xu, Y.

2026-03-26 neuroscience
10.64898/2026.03.24.713853 bioRxiv
Show abstract

Mutations in ANXA11 cause amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), yet the mechanisms linking ANXA11 dysfunction to neurodegeneration remain poorly defined. Recent cryo-EM studies revealed heteromeric ANXA11-TDP-43 filaments in patient brains, suggesting a direct pathological connection between these two ALS-associated proteins. However, whether ANXA11 possesses intrinsic amyloidogenic properties and how its aggregation relates to TDP-43 proteinopathy remain unknown. Here, we demonstrate that ANXA11 undergoes liquid-liquid phase separation and subsequently matures into amyloid fibrils through a liquid-to-solid phase transition. ANXA11 fibrils exhibit prion-like properties, including self-templating seeding activity and intercellular propagation in human iPSC-derived neurons. Strikingly, ANXA11 fibrils induces pathological conversion of TDP-43, including hyperphosphorylation, accumulation in detergent-insoluble fractions, and formation of cytoplasmic aggregates. TurboID proximity-labeling proteomics further revealed aggregation-dependent enrichment of nuclear pore complex and nucleocytoplasmic transport factors in the ANXA11 aggregate-proximal proteome. Consistently, ANXA11 aggregation was associated with nuclear envelope abnormalities, altered nucleoporin distribution, impaired mRNA export, and progressive neuronal toxicity in iPSC-derived neurons. Together, these findings establish ANXA11 as an intrinsically amyloidogenic, phase-transition-competent protein whose seeded assemblies propagate between cells, induce TDP-43 co-pathology, and are linked to nucleocytoplasmic transport defects and neuronal injury, thereby providing a mechanistic framework for ANXA11-associated ALS/FTD pathogenesis. Graphic Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=188 SRC="FIGDIR/small/713853v1_ufig1.gif" ALT="Figure 1"> View larger version (60K): org.highwire.dtl.DTLVardef@1aaad3org.highwire.dtl.DTLVardef@c51d5eorg.highwire.dtl.DTLVardef@10b2891org.highwire.dtl.DTLVardef@1945575_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIANXA11 undergoes liquid-liquid phase separation and matures into amyloid fibrils through a liquid-to-solid phase transition. C_LIO_LIANXA11 fibrils supports homotypic seeding and propagate within SH-SY5Y cells and iPSC-derived neurons. C_LIO_LIANXA11 fibrils induce TDP-43 pathological conversion, including phosphorylation and accumulation in insoluble aggregates. C_LIO_LIANXA11 aggregation is associated with nuclear pore complex remodeling, impaired mRNA export, and neuronal toxicity. C_LI In BriefANXA11 undergoes phase separation and matures into prion-like amyloid fibrils through a liquid-to-solid transition. These seeded assemblies propagate between cells and human neurons, induce TDP-43 pathological conversion, and are associated with remodeling of nuclear pore complexes, impaired mRNA export, and progressive neuronal toxicity. ANXA11 forms seeded amyloid assemblies that spread between cells, induce TDP-43 pathology, and disrupt nucleocytoplasmic transport.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 19%
9.9%
2
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 8%
8.1%
3
Cell Reports
1338 papers in training set
Top 6%
6.7%
4
Neuron
282 papers in training set
Top 2%
6.7%
5
Advanced Science
249 papers in training set
Top 4%
4.8%
6
The EMBO Journal
267 papers in training set
Top 0.2%
3.9%
7
Cell
370 papers in training set
Top 5%
3.9%
8
Alzheimer's & Dementia
143 papers in training set
Top 1%
3.9%
9
Nature Neuroscience
216 papers in training set
Top 3%
3.5%
50% of probability mass above
10
Brain
154 papers in training set
Top 2%
3.0%
11
Science Advances
1098 papers in training set
Top 10%
2.7%
12
Nature
575 papers in training set
Top 8%
2.6%
13
EMBO Molecular Medicine
85 papers in training set
Top 1%
2.3%
14
Immunity
58 papers in training set
Top 2%
1.9%
15
Science
429 papers in training set
Top 13%
1.9%
16
Developmental Cell
168 papers in training set
Top 8%
1.7%
17
eLife
5422 papers in training set
Top 43%
1.7%
18
Molecular Neurodegeneration
49 papers in training set
Top 0.6%
1.5%
19
Acta Neuropathologica
51 papers in training set
Top 0.7%
1.5%
20
Science Translational Medicine
111 papers in training set
Top 3%
1.5%
21
Nature Medicine
117 papers in training set
Top 3%
1.3%
22
Neurobiology of Disease
134 papers in training set
Top 3%
1.3%
23
Journal of the American Chemical Society
199 papers in training set
Top 4%
1.3%
24
Journal of Clinical Investigation
164 papers in training set
Top 4%
1.2%
25
Molecular Cell
308 papers in training set
Top 9%
0.9%
26
eneuro
389 papers in training set
Top 8%
0.9%
27
Cell Chemical Biology
81 papers in training set
Top 3%
0.8%
28
iScience
1063 papers in training set
Top 30%
0.8%
29
JCI Insight
241 papers in training set
Top 7%
0.7%
30
Structure
175 papers in training set
Top 3%
0.7%